KB Isayeva

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Results At 54 week 100% and 87.5% patients with early and long-standing JIA respectively achieved at least 50% response. After 2 years ACR-Pedi 70/90 response to infliximab was recorded in all patients with early JIA and 100%/88.9% of patients with long-standing JIA respectively. At weeks 54 following infliximab treatment, 89% and 60% of patients with early(More)
  • 1